| Director/PDMR Shareholding | RNS | 28.06.22 | 17:56:43 |
| GSK files Shingrix 18+ at risk indication in Japan | RNS | 28.06.22 | 07:00:07 |
| Director/PDMR Shareholding | RNS | 27.06.22 | 16:08:13 |
| Director/PDMR Shareholding | RNS | 24.06.22 | 15:44:50 |
| Director/PDMR Shareholding | RNS | 16.06.22 | 10:58:21 |
| Positive phase III data for GSK’s RSV OA vaccine | RNS | 10.06.22 | 07:00:08 |
| Director/PDMR Shareholding | RNS | 09.06.22 | 16:28:40 |
| Director/PDMR Shareholding | RNS | 07.06.22 | 17:17:08 |
| US FDA approval of Priorix | RNS | 06.06.22 | 07:00:09 |
| Total Voting Rights | RNS | 01.06.22 | 16:55:33 |
| Demerger update: Publication of Documents | RNS | 01.06.22 | 13:00:02 |
| Demerger update: Submission of Documents to FCA | RNS | 01.06.22 | 07:00:10 |
| GSK to acquire Affinivax, Inc. | RNS | 31.05.22 | 07:00:05 |
| Further appointments to Designate Haleon Board | RNS | 30.05.22 | 10:00:02 |
| GSK Cervarix two-dose schedule approved by NMPA | RNS | 27.05.22 | 07:00:02 |
| Director/PDMR Shareholding | PRN | 25.05.22 | 15:41:00 |
| Director/PDMR Shareholding | RNS | 23.05.22 | 15:21:33 |
| Iain Mackay - External Appointment | RNS | 19.05.22 | 10:02:29 |
| Change of name to GSK plc | RNS | 16.05.22 | 14:00:03 |
| Director/PDMR Shareholding | RNS | 13.05.22 | 17:13:23 |
